TEVA logo

TEVA Short-Term Debt

Latest reported$4.50B
TEVA Quarterly Short-Term Debt ($14.70M → $4.50B)
High-resolution chart · PNG

TEVA short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
4,500,000,000
2,612,031,000
1,820,000,000
24,000,000
464,000,000
421,000,000
1,781,000,000
2,580,000,000
2,094,000,000
3,060,000,000
1,672,000,000
1,479,000,000
1,980,000,000
1,023,000,000
2,109,000,000
2,769,000,000
1,719,000,000
2,077,000,000
1,426,000,000
2,709,000,000
3,530,000,000
2,697,000,000
3,188,000,000
2,106,000,000
1,649,000,000
1,630,000,000
2,345,000,000
3,246,000,000
2,891,000,000
2,904,000,000
2,216,000,000
2,673,000,000
1,272,000,000
1,302,000,000
3,646,000,000
2,731,000,000
1,246,000,000
1,942,000,000
3,276,000,000
3,676,000,000
2,989,000,000
1,592,000,000
1,585,000,000
2,148,000,000
3,022,000,000
1,626,000,000
-5,351,000,000
1,832,000,000
2,048,000,000
1,552,000,000
-4,603,000,000
2,537,000,000
2,536,000,000
2,720,000,000
3,006,000,000
1,102,000,000
1,420,000,000
4,365,000,000
3,749,000,000
3,814,000,000
2,458,000,000
1,877,000,000
1,432,000,000
2,408,000,000
1,946,000,000
1,974,000,000
1,301,000,000
1,476,000,000
2,028,000,000
3,356,000,000
2,906,000,000
744,000,000
1,429,000,000
2,032,000,000
1,841,000,000
1,952,000,000
1,524,000,000
1,521,000,000
742,000,000
737,200,000
1,055,900,000
1,061,800,000
375,500,000
390,000,000
419,500,000
502,600,000
560,000,000
445,200,000
694,300,000
708,300,000
644,200,000
1,158,800,000
789,900,000
770,500,000
738,500,000
164,300,000
151,700,000
155,300,000
206,523,000
207,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.